# A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects

> **NCT00460954** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 20 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Sinemet® controlled release (Carbidopa/levodopa)

## Key facts

- **NCT ID:** NCT00460954
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2008-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00460954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00460954, "A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00460954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*